BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 94 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EAM Investors, LLC | 129,929 | $603,000 | 0.19% |
| ABNER HERRMAN & BROCK LLC | 56,050 | $260,000 | 0.06% |
| CFO4Life Group, LLC | 12,000 | $56,000 | 0.03% |
| Spark Investment Management LLC | 12,000 | $55,000 | 0.03% |
| Phoenix Holdings Ltd. | 118,533 | $534,000 | 0.03% |
| HighPoint Advisor Group LLC | 13,533 | $82,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 12,500 | $58,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 66,197 | $299,000 | 0.01% |
| WINTON GROUP Ltd | 76,967 | $357,000 | 0.01% |
| IHT Wealth Management, LLC | 13,000 | $60,000 | 0.01% |